![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » SOLVAY CONSIDERING BUYING UCB'S PEPTIDES UNIT -- SOURCE
SOLVAY CONSIDERING BUYING UCB'S PEPTIDES UNIT -- SOURCE
November 23, 2005
Pharmaceutical group Solvay SA is considering buying peer UCB SA's peptides unit UCB-Bioproducts, according to a source close to the company. The information is consistent with claims made in an earlier press report. 'According to my information, the article in De Tijd is right, ' said the source. 'The market is structured in such a way that all the players in that market will look at it,' the source added.
Forbes (http://www.forbes.com/home/feeds/afx/2005/11/22/afx2350068.html)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct